SAN FRANCISCO--(BUSINESS WIRE)--Woebot Health today announced that it has won the “Mental Health Innovation Award” in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market. The honor recognizes the Woebot Health Platform, which is built on a foundation of clinically proven techniques and infused with artificial intelligence (AI). The platform offers instantly accessible, chat-based, adjunctive mental health support and the tools and insights needed to enhance the care experience, automate the collection of population insights and increase provider efficiency. The award also recognizes Woebot, the digital companion at the heart of the platform that delivers personalized, in-the-moment support through chat-based conversations and techniques. Woebot's conversations are written by conversational writers using elements from evidence-based approaches like Cognitive Behavioral Therapy (CBT), Interpersonal Psychotherapy (IPT) and Dialectical Behavioral Therapy (DBT), along with collaboration from clinical experts. “We’re thrilled and honored to once again receive an award from MedTech Breakthrough,” said Woebot Health CEO Michael Evers

The mental health arena is buzzing with the entry of AI-powered apps that promise fast and accessible care. Amid soaring demand for mental health support, artificial intelligence (AI) apps are sparking debate among experts. These tools offer hope for bridging care gaps but come with concerns over efficacy and ethics. As the field navigates this digital wave, experts say the challenge lies in determining whether AI can genuinely complement the human touch in mental health care or if it serves merely as a high-tech stopgap. “AI is incredibly useful for mental health apps because it can personalize care at scale, offering tailored support and interventions based on individual user data,” Derek Du Chesne, CEO of Better U, a mental wellness company, and creator of the Better U mental wellness app and patient portal, told PYMNTS

NEW YORK, March 19, 2024 /PRNewswire/ -- Lindus Health , the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched an all-in-one package of contract research organization (CRO) services tailored for CNS, neurology, and psychiatric clinical trials. The "All-In-One CNS, Neurology and Psychiatry CRO" empowers sponsors within these therapeutic areas to execute more nimble and successful clinical trials.Sponsors will have access to traditional full-service CRO expertise, internal site, and Principal Investigator (PI) knowledge, all enhanced by Lindus Health's innovative Citrus™ technology platform. With a solid background in managing CNS studies, Lindus Health has successfully completed 28 end-to-end trials across CNS, Neurology, and Psychiatry involving over 8,000 participants across the US, UK, and Europe to date, addressing 16 disease indications within this therapeutic area."Neuro studies notoriously have a high failure rate compared to other disease areas for many reasons. Some of these are beyond our control, but in general they require longer follow-up periods and more intensive recruitment and retention tactics due to the nature of these conditions," said Samantha Brooks, Trial Manager at Lindus Health. "I am enthusiastic about the launch of our 'All-In-One CNS, Neurology and Psychiatric CRO' offering, so we can greatly improve the logistical barriers that hold these trials back from seeing success."Lindus Health has garnered respect for its efficacy in advancing neurology and psychiatric solutions to the market, backed by a prestigious advisory board that includes the likes of Robert Langer , a noted MIT professor and Moderna co-founder, alongside Acacia Parks , CMO at Allico with over 20 years of experience in the mental health space.Lindus Health has had the privilege of taking on numerous exciting trials with the potential to change the way patients receive treatment and care for their neurological and psychiatric conditions. They've collaborated with sponsors including CoMind , Pharmanovia , Woebot Health , Arcade Therapeutics , Sanna Science , and more.The "All-in-One CNS, Neurology and Psychiatric CRO" offering from Lindus Health encompasses:Comprehensive trial management and execution: From protocol design and participant recruitment to data management and reporting, Lindus Health's clinical operations team resumes vast experience in all aspects of CNS and psychiatry study execution.From protocol design and participant recruitment to data management and reporting, Lindus Health's clinical operations team resumes vast experience in all aspects of CNS and psychiatry study execution